Sort
23,748 grants matching “melanoma”
Chemerin in Tumor Immunity and Surveillance
$292,575Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2015 · CA
Chemerin in Tumor Immunity and Surveillance
$292,575Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2017 · CA
Chemerin in Tumor Immunity and Surveillance
$292,575Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2013 · CA
Chemerin in Tumor Immunity and Surveillance
$292,575Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2016 · CA
LPD Nanoparticles in Anti-Cancer Therapy
$292,520Leaf Huang · Univ Of North Carolina Chapel Hill · R01 · FY2012 · CA
Tumor-Reactive Immune Cells Generated from Drosphila Antigen Presenting Cells
$292,502James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Identification of Molecular Factors Associated with Response to Interleukin-2
$292,502James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Non-invasive imaging of the immune response based on the use of isotopically labeled single domain antibody fragments
$292,500Hidde L Ploegh · Whitehead Institute For Biomedical Res · R21 · FY2015 · AI
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis
$292,473Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2022 · CA
PTEN Nuclear-Cytoplasmic Localization in Breast Cancer
$292,442Charis Eng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · CA
PTEN Nuclear-Cytoplasmic Localization in Breast Cancer
$292,442Charis Eng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2009 · CA
PTEN Nuclear-Cytoplasmic Localization in Breast Cancer
$292,442Charis Eng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2008 · CA
Administration, Evaluation, and Planning
$292,405Elizabeth A Grimm · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA
Epidemiologic Architedure of Lung Cancer and Smoking
$292,402Christopher I. Amos · University Of Tx Md Anderson Can Ctr · U19 · FY2010 · CA
Molecular Classification of Primary Cutaneous Melanoma
$292,363Mohammed Kashani-Sabet · University Of California, San Francisco · R01 · FY2007 · CA
Prevention of UV-carcinogenesis through DNA methylation-dependent immunomodulation
$292,343Santosh Kumar Katiyar · Morehouse School Of Medicine · R01 · FY2018 · CA
Project 2
$292,318Ryan Bruce Corcoran · Massachusetts General Hospital · U54 · FY2019 · CA
The GNAQ pathway as a therapeutic target in uveal melanoma
$292,312Boris C Bastian · University Of California, San Francisco · R01 · FY2013 · CA
Plexin signalling in melanocyte biology and melanoma progression
$292,312Glynis A Scott · University Of Rochester · R01 · FY2013 · CA
Cancer Biology Research Test-Bed Unit 2: Effects of cell-intrinsic and cell-extrinsic variations in lipid metabolism on metastasis patterns
$292,219Sean J Morrison · Ut Southwestern Medical Center · U54 · FY2023 · CA
TUMOR AND IMMUNO-METABOLISM BASED LACTATE TRANSPORTER INHIBITORs FOR METASTATIC MELANOMA
$292,210Vincent Sandanayaka · Nirogyone Therapeutics, Llc · R43 · FY2019 · CA
Regulation of apoptosis by mutationally activated B-Raf
$292,182Martin McMahon · University Of California, San Francisco · R01 · FY2006 · CA
Potentiating Adoptive T Cell Therapy by Immunomodulation
$292,160Cassian Yee · Fred Hutchinson Cancer Research Center · R21 · FY2009 · CA
CD24 in Cancer Resistance and Immunotherapy
$292,144Yang Liu · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
CD24 in Cancer Resistance and Immunotherapy
$292,144Yang Liu · University Of Michigan At Ann Arbor · R01 · FY2009 · CA